• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $BACQ

    Inflection Point Acquisition Corp. IV

    Subscribe to $BACQ
    $BACQ
    00

    IPO Year: 2024

    Exchange: NASDAQ

    Recent Analyst Ratings for Inflection Point Acquisition Corp. IV

    DatePrice TargetRatingAnalyst
    See more ratings

    Inflection Point Acquisition Corp. IV Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million

    Inflection Point and investors increase PIPE commitments to more than $200 million, including over $85 million of pre-funded PIPE capital Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, and Inflection Point Acquisition Corp. IV (NASDAQ:BACQ) ("Inflection Point") today announced a significant increase to their previously disclosed private investment in public equity ("PIPE"). The increase comes from both new investors and existing investors increasing their commitments, bringing total PIPE commitments to more than $200 million, of which over $85 million has already been funded. This represents a substantial increase from t

    11/17/25 9:00:00 AM ET
    $BACQ

    Merlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market Readiness

    Carrithers brings to Merlin a unique blend of technical expertise, capital markets experience, and operational rigor, backed by a proven record in scaling innovative automation and aerospace companies Merlin Labs, Inc., a leading developer of assured, autonomous flight technology for defense customers, today appointed Ryan Carrithers as its new Chief Financial Officer. Carrithers joins Merlin at a pivotal moment as the company prepares to go public in a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). In this role, he will oversee all of Merlin's financial operations and strategy, investor relations, M&A or strategic partnerships that support its autonomy road

    11/4/25 9:00:00 AM ET
    $ASTR
    $BACQ
    $DNA
    Transportation Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Merlin Collaborates with United States Air Force to Advance Autonomous Contingency Management Capabilities

    The collaboration will focus on enhancing the government's Autonomy-Government Reference Architecture (A-GRA) to support advanced contingency management for next-generation uncrewed and collaborative air systems Merlin, a leading developer of assured, autonomous flight technology for defense customers, today announced the signing of a Cooperative Research and Development Agreement (CRADA) with the United States Air Force (USAF) to advance autonomous capabilities that will improve mission resilience and adaptability in contested and degraded environments. The work will combine operational insight from the USAF with Merlin's expertise in autonomy architecture, human-machine teaming, and adv

    10/22/25 9:00:00 AM ET
    $BACQ

    Merlin to Go Public via Business Combination with Inflection Point-led SPAC as Leading Defense Prime Contractor for AI in Aviation

    Transaction values Merlin at $800 million pre-money and is designed to drive rapid capability delivery for customers as well as bolster strategic acquisition pipeline Over $125 million of capital committed, anchored by Inflection Point fund, existing Merlin investors including Baillie Gifford, and several new institutional investors The transaction positions Merlin to scale critical AI-enabled autonomous flight capabilities while continuing to support national security in a rapidly evolving defense landscape Inflection Point's track record of closing successful SPAC deals includes Intuitive Machines and USA Rare Earth Merlin, a leading developer of assured, autonomous flight te

    8/14/25 8:33:00 AM ET
    $BACQ
    $LUNR
    $USAR
    Industrial Machinery/Components
    Industrials
    Metal Mining
    Basic Materials

    Inflection Point Acquisition Corp. IV Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Folino Robert

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    7/21/25 4:15:19 PM ET
    $BACQ

    SEC Form 3 filed by new insider Shannon Kevin George

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    7/21/25 4:15:21 PM ET
    $BACQ

    SEC Form 3 filed by new insider Blitzer Michael

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    7/21/25 4:15:22 PM ET
    $BACQ

    SEC Form 3 filed by new insider Padula Marcello J.

    3 - Bleichroeder Acquisition Corp. I (0002028707) (Issuer)

    5/16/25 4:15:22 PM ET
    $BACQ

    Inflection Point Acquisition Corp. IV SEC Filings

    View All

    SEC Form 425 filed by Inflection Point Acquisition Corp. IV

    425 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/19/25 9:11:38 AM ET
    $BACQ

    SEC Form 425 filed by Inflection Point Acquisition Corp. IV

    425 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/18/25 4:30:01 PM ET
    $BACQ

    SEC Form 425 filed by Inflection Point Acquisition Corp. IV

    425 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/17/25 9:24:21 AM ET
    $BACQ

    Inflection Point Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Filer)

    11/17/25 9:21:36 AM ET
    $BACQ

    Amendment: SEC Form SCHEDULE 13G/A filed by Inflection Point Acquisition Corp. IV

    SCHEDULE 13G/A - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/14/25 11:20:10 AM ET
    $BACQ

    Amendment: SEC Form SCHEDULE 13G/A filed by Inflection Point Acquisition Corp. IV

    SCHEDULE 13G/A - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/14/25 6:03:24 AM ET
    $BACQ

    SEC Form 10-Q filed by Inflection Point Acquisition Corp. IV

    10-Q - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Filer)

    11/12/25 5:15:45 PM ET
    $BACQ

    Amendment: SEC Form SCHEDULE 13G/A filed by Inflection Point Acquisition Corp. IV

    SCHEDULE 13G/A - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/12/25 4:07:00 PM ET
    $BACQ

    SEC Form 425 filed by Inflection Point Acquisition Corp. IV

    425 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    11/4/25 9:09:42 AM ET
    $BACQ

    SEC Form 425 filed by Bleichroeder Acquisition Corp. I

    425 - INFLECTION POINT ACQUISITION CORP. IV (0002028707) (Subject)

    10/28/25 9:26:51 AM ET
    $BACQ

    Inflection Point Acquisition Corp. IV Leadership Updates

    Live Leadership Updates

    View All

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Merlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market Readiness

    Carrithers brings to Merlin a unique blend of technical expertise, capital markets experience, and operational rigor, backed by a proven record in scaling innovative automation and aerospace companies Merlin Labs, Inc., a leading developer of assured, autonomous flight technology for defense customers, today appointed Ryan Carrithers as its new Chief Financial Officer. Carrithers joins Merlin at a pivotal moment as the company prepares to go public in a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). In this role, he will oversee all of Merlin's financial operations and strategy, investor relations, M&A or strategic partnerships that support its autonomy road

    11/4/25 9:00:00 AM ET
    $ASTR
    $BACQ
    $DNA
    Transportation Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care